Resolution Therapeutics and CCRM sign collaboration agreement to develop and scale up manufacturing for induced pluripotent stem cell (iPSC)-derived macrophage cell therapies

Subscribe to our mailing list to receive CCRM’s monthly newsletter.

 
 

You have Successfully Subscribed!